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Abstract: E-health technologies improve healthcare quality and disease management. The aim of
this study was to develop a ketogenic diet management app as well as a website about this dietary
treatment and to evaluate the benefits of giving caregivers access to various web materials designed
for paediatric patients with refractory epilepsy. Forty families participated in the questionnaire
survey, from January 2016 to March 2016. All caregivers were exposed to paper-based materials
about the ketogenic diet, whereas only 22 received the app, called KetApp, and videos produced
by dieticians. Caregivers with free access to web materials were more satisfied than the others
with the informative material provided by the centre (p ≤ 0.001, Mann–Whitney test). Indeed, they
showed a better attitude towards treatment, and they became more aware of dietary management
in comparison to the control group (p ≤ 0.001). Moreover, caregivers provided with web materials
were stimulated to pursue the treatment (p = 0.002) and to introduce it to their children and other
people (p = 0.001). Additionally, caregivers supplied with web materials were more willing to help
other families in choosing the ketogenic diet (p = 0.004). Overall, these findings indicate that web
materials are beneficial for caregivers of paediatric patients with refractory epilepsy in our centres.
Thus, the use of e-health applications could be a promising tool in the daily aspects of ketogenic
diet management, and it is especially of value in the attempt to start or maintain the diet during the
ongoing COVID-19 pandemic crisis.
Keywords: COVID-19 pandemic; dietary management; drug-resistant epilepsy; E-health applica-
tions; Italy; ketogenic diet; smart technology; smartphone app
1. Introduction
E-health applications are based on the use of information and communications tech-
nologies in support of health-related fields, such as healthcare services, health surveillance,
health literature, knowledge, and research [1]. These tools have the potential to remarkably
enhance health service efficiency, accessibility and delivery to thousands of patients, as
well as to improve patient outcomes [1,2]. For this reason, the use of e-health technologies
to provide innovative solutions for disease management has raised patients’, caregivers’,
and health professionals’ hopes [2].
In recent years, the use of instant messaging services [3,4], the development of a large
variety of smartphone applications (apps) [2,5,6] and online platforms (e.g., Zoom, Polycom,
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or Doximity) [7] have led to improved communication within medical teams and family
caregivers by simplifying information sharing, early treatment initiation, and therapy
management. During the ongoing COVID-19 pandemic, e-health applications have been
intensively used to reduce the risk of cross-contamination caused by close contact. Indeed,
the adoption of e-health solutions has been remarkably important to continue providing
knowledge and information to patients and caregivers while attempting to “flatten the
curve” of the increasing number of COVID-19 cases [8]. Interestingly, smartphone apps
are appreciated because they are easily accessible, acceptable, and able to support social
distancing efforts [8]. Concerning the development of apps, some of them seem to be
designed for healthcare professionals, whereas others are most suitable as patient-centred
apps. Furthermore, some apps can cover a wide range of clinical knowledge, and others
can be tailored to specific diseases/disorders [2,9]. For instance, apps for epileptic seizure
self-management have been employed in Australia and the United States [10,11]. Also,
smartphone apps for seizure self-management would be well-accepted by patients with
epilepsy in China [5].
In general, particular attention must be paid to the management of treatments for
drug-resistant epilepsy. For instance, the ketogenic diet is a high-fat, low-carbohydrate
and normal protein diet and is used to control antiseizure drug-refractory epilepsy [12,13].
Indeed, the classical 4:1 ketogenic diet seems to be effective in up to 55% of children
with refractory seizures after three months [14]. During the coronavirus outbreak, the
management of children with drug-resistant epilepsy on ketogenic diet therapies through
telemedicine has been demonstrated to be feasible and well-received by the families and pa-
tients in Argentina [3] and the United States [7]. In Italy, specific guidelines and therapeutic
approaches for the care of patients undergoing a ketogenic diet, especially in an acute med-
ical setting, should be improved [15], as the introduction of this specific treatment requires
an abrupt change of eating habits and a constant monitoring of possible side effects [16–18].
Indeed, the ketogenic diet aims at switching the brain metabolism from glucose dependence
to the utilisation of ketone bodies. For this reason, it requires a limited consumption of
cereal-based foods and a reduction in fruit and vegetable intake. In this dietary treatment,
the low variability, palatability and tolerability can be compensated by food products
commercialised by specific food companies. Similarly, side effects, such as gastrointestinal
disorders, nephrolithiasis, growth retardation, hyperlipidaemia and mineral and vitamin
deficiency should be avoided with the help of health professionals [19]. Notably, even
if e-health technologies and the use of remote monitoring by telecommunications have
recently increased in Italy [16,20], adequate information for long-term management of
the ketogenic diet cannot be easily found by patients and caregivers [21]. For this reason,
patients and caregivers’ free access to different e-health resources should play a key role in
the dietary management of drug-resistant epilepsy.
Here, we evaluate family caregivers’ satisfaction to assess the feasibility and accept-
ability in our centres of using different web materials, including smartphone apps, websites
and videos, for the management of paediatric patients with refractory epilepsy and main-
tained on a ketogenic diet. Specifically, to assess the beneficial effects of web materials
specifically designed for caregivers and paediatric patients with a diagnosis of refractory
epilepsy and treated with the ketogenic diet, we carried out an analysis aimed to compare
the value of paper-based informative materials and web-based ones.
2. Materials and Methods
2.1. Patients
We considered a cohort of paediatric patients with a diagnosis of refractory epilepsy
still treated at the time of the survey or, alternatively, treated in the past with the ketogenic
diet. Particularly, children and their families were recruited in the Policlinico Hospital
(Modena), in the Meyer Hospital (Florence), and in the “Bambino Gesù” Children’s Hospital
(Rome). The inclusion criteria were a confirmed diagnosis of epilepsy, refractoriness to
antiepileptic drugs, age ranging from 0 to 17 years, and informed consent signed by
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parents. At variance, exclusion criteria were acute or chronic metabolic diseases unrelated
to epilepsy and the lack of adherence to the nutritional protocol. Particularly, the lack
of adherence to the nutritional protocol was assessed by interviews during the routine
checkup and phone calls. Moreover, the lack of adherence was also assessed by monitoring
the blood glucose value (mg/dL), as well as the ketosis (mmol/L) and seizure occurrence
during the routine checkup and/or by means of the smartphone app named KetApp.
Specifically, the final ratio of lipids and proteins + carbohydrates that patients should
reach was 2/4:1, and the dietary treatment also needed to be monitored and supplemented
as previously detailed [17]. The Ethics Committee of Modena (4206/C.E.) approved the
research protocol according to local regulations, and informed written consent was obtained
from relatives of patients.
2.2. Caregivers
Caregivers were defined as the family members (e.g., parents and grandparents) or
other family delegates (e.g., nannies), who were primarily responsible for providing every-
day care for the child [22]. Indeed, caregivers were directly involved in the management
of the ketogenic diet, such as cooking meals, and they oversaw the strict dietary rules of
the treatment.
2.3. Questionnaire
The questionnaire followed the structure of the Information Satisfaction Questionnaire
(ISQ) [23] and aimed at evaluating the quality of the information under examination consid-
ering comprehensiveness, accuracy, credibility, relevance, and suitability. The questionnaire
was written using simple language, as was suggested in the guidelines provided by the
working group for health literacy of the health section of Emilia-Romagna Region. The
questionnaire was completed by volunteer caregivers from January 2016 to March 2016.
As reported in our previous study [21], the aim was to evaluate their perception of and
satisfaction with the informative materials regarding the ketogenic diet. The questionnaire
was written using a simple language and it was anonymous [21]. The questionnaire was
detailed in our previous study [21], and it was divided into four sections with the following
titles: (1) General information; (2) Where did you find preliminary information about the
ketogenic diet? (3) Can you evaluate the informative materials on the ketogenic diet given
by the centre that follows your child? (4) Suggestions to improve the information for fami-
lies. Except for the last section, the questionnaire comprised multiple-choice questions with
a 5-point Likert that ranged from 1 (strongly disagree) to 5 (strongly agree). To compare
the efficacy of paper-based materials with web-based ones, we decided to improve the
analysis of the third section that was divided into four sub-sections: (i) booklets/leaflets,
(ii) website, (iii) app, and (iv) the overall material [21]. Parents were asked only to complete
the sub-sections dealing with the informative materials they were provided.
2.4. Booklets
The booklets represented paper-based information, consisting of an average of 30 pages
with a combination of text and images. One booklet was produced by the medical nu-
trition company “Nutricia”, whereas the other two were produced by the participating
hospital centres [21]. The booklets were distributed during doctor–caregiver encounters by
health operators.
2.5. Website
The website was created specifically for this research in 2016. Particularly, the first ver-
sion of the website, available in 2016, was accessible only using a username and password
provided by the dietician. In 2020, we implemented our Italian website created by health
professionals, and then the second version of the website (www.dietachetogenica.unimore.
it) became fully accessible.
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2.6. App
KetApp is a tool, created by the University of Modena and Reggio Emilia, designed to
assist nutritional compliance for all patients on a ketogenic diet. Twenty-two caregivers
were given access to the pre-release version of the app, through usernames and passwords
provided by the dietician. Data collected by the app were output in Word and Excel, and
then sent by email.
2.7. Videos
The videos of the Keto recipes were directly created by the dietician of the Policlinico
Hospital (Modena). The videos were reviewed during doctor–caregiver encounters, to
explain how to follow a ketogenic diet in an interactive way.
2.8. Statistical Analysis
Data were analysed using Sigma Plot 11 (Systat Software, San Jose, CA, USA). The
group that was given access only to the paper-based materials and the group that also
had access to web-based materials were compared by the Mann–Whitney test. Results are
shown as medians and interquartile ranges and considered significant at p < 0.05.
3. Results
3.1. Characterisation of Paediatric Patients and Their Families
A total of 40 paediatric patients and their families participated to our study. Particu-
larly, 33 children and their families were recruited in the Policlinico Hospital, five in the
Meyer Hospital, and two in the “Bambino Gesù” Children’s Hospital. According to our
previous study, in which we presented a detailed characterisation of the patients and their
caregivers [21], paediatric patients were mainly represented by girls (65.0%) with an age
ranging from 4 to 6 years (42.5%). At variance, most of the caregivers were mothers (60.0%)
of Italian nationality (77.5%). Generally, caregivers ranged in age from 30 to 40 (60.0%) and
held a junior high school degree (40.0%). Moreover, 90.0% of caregivers could access the
Internet. However, 52.1% found the preliminary information about the dietary therapy
only through health institutions.
At the time of the questionnaire (2016), the majority of children were still treated with
the ketogenic diet (62.5%) and had been following the treatment plan for two years on
average. In the current year (2021), only five families and their children are still using the
web materials since they completed the questionnaire in 2016.
All caregivers had free access to paper-based informative materials, and they consid-
ered booklets readable (65.0% of 4 = I agree) and understandable (60.0% of 4 = I agree).
However, they also observed that booklets were neither satisfactory nor adequate to make
an informed choice (62.5% of 2 = I disagree) and to explain the ketogenic diet to other
people who might be interested in it (57.5% of 2 = I disagree, and 25.0% of 1 = I strongly
disagree) [21].
Notably, foreign caregivers with difficulty in understanding Italian asked for translated
versions of informative materials, or at least with easier language, and to provide ethnic
recipes respecting cultural differences in the use of food [21].
3.2. The Design of an Italian Website about the Ketogenic Diet
The website called “www.dietachetogenica.unimore.it” provided information about
the ketogenic diet, and the menu of the website was divided into six different sections. The
first section concerns the diet: (i) history; (ii) mechanism of action; (iii) therapeutic implica-
tions in several diseases (e.g., glucose transporter type 1 deficiency syndrome, pyruvate
dehydrogenase deficiency, obesity, Dravet syndrome, West syndrome, Lennox–Gastaut
syndrome, migraine, diabetes, Parkinson’s disease, Alzheimer’s disease, amyotrophic
lateral sclerosis, ageing, and brain tumours); (iv) contraindications; (v) clinical monitoring;
(vi) variations to the classic protocol (e.g., the modified Atkins diet, the medium-chain
triglyceride diet, and the low glycaemic diet); (vii) ketogenic artificial nutrition; (viii) mon-
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itoring of side effects; (ix) allowed food; (x) hidden sources of carbohydrates; (xi) first
ketogenic grocery shopping; (xii) food labels; (xiii) ketogenic starter kit; (xiv) ketogenic
diet at home; (xv) ketogenic diet at school; (xvi) flavours and frequencies of consump-
tion. The second section regards epilepsy, epileptic seizures, antiepileptic treatment, and
pharmacological tolerability. Finally, the third section focuses on the autosomal dominant
polycystic kidney disease, giving an overview on the tolvaptan treatment and new treat-
ment prospects. The last sections concern information about the article and publications,
app, and research group.
3.3. The Design of an Italian App for the Management of the Ketogenic Diet
KetApp was primarily developed as an Italian pre-release version, which was strongly
supported by health professionals as a way to help caregivers after the release of children
who were affected by drug-resistant epilepsy from the Policlinico Hospital (Modena).
The architecture was designed to be easy to understand. The app allows to: (i) record
diet parameters (e.g., daily intake of macro- and micro-nutrients, daily kilocalories and
ratios agreed upon with the dietician); (ii) generate daily and weekly receipts and menus;
(iii) record blood glucose and ketosis values; (iii) record the anthropometric data (e.g.,
weight and height) and monitor them over time; (iv) record epileptic seizure data (e.g., day,
hour, duration, description of the seizures, and all actions taken).
In the following figures, the values refer to a child undergoing, for example, a dietary
therapy (1000 Kcal/day) with a final ratio of lipids and proteins + carbohydrates equal
to 3:1. In Figure 1, we report an example of how to learn about the nutritional facts of
each food and create new daily or weekly menus. Particularly, the first option of the
drop-down menu refers to food management (“gestione alimenti”). By clicking on this
option (Figure 1A), it is possible to search for different types of food (e.g., salmon), and
their nutritional values, per 100 g (Figure 1B,C). Then, it is possible to manage the meals
(“gestione pasti”) and create new recipes by choosing different foods from the list. Both
main meals and snacks should agree with the daily kilocalories and ratios approved by
the dietician (Figure 1D,E). Once a new main meal (e.g., code: PASTO 001) or snack (e.g.,
code: SNACK 001) has been created, it is possible to use it in the weekly menu (“menu
settimanale”). For instance, “PASTO 001” and “SNACK 001” were used in the menu for
Monday (Figure 1F,G).
In Figure 2, we report a usage example to record blood glucose (“monitoraggio
glicemia”) and ketosis values (“monitoraggio chetosi”). Indeed, for both parameter options
(Figure 2A), it is possible to record the day and hour of measurement (Figure 2B,D) and
monitor them over time with a graph (“grafico dieta”; Figure 2C,E).
In Figure 3, we show how to record the anthropometric data (“antropometria”) and
the number and type of seizures (“record crisi”) over time (Figure 3A). In this regard, both
weight (“peso”) and height (“altezza”) parameters can be recorded in the app (Figure 3B–E).
The different types of seizures (e.g., focal with or without impaired awareness, absence,
tonic, atonic, clonic, myoclonic, or tonic–clonic) can also be reported (Figure 3F,G) and
monitor over time with a graph (“grafico dieta”; Figure 2E).
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Figure 1. Using the app to learn about the nutritional facts of each food and create new daily or
weekly menus. The logo and the first part of the drop-down menu are reported in (A). An example
of food management (“gestione alimenti”) is reported in (B,C). An example of meal management
(“gestione pasti”) is reported in (D,E). Particularly, in the section dedicated to meal management,
the suggested nutritional values (“valori nutrizionali consigliati”) are above the list of inserted
food, whereas the selected nutritional values (“valori nutrizionali pasto corrente”) are placed under
the list. An example of a weekly menu (“menu settimanale”) with a weekly summary (“riepilogo
settimanale”) is reported in (F,G).
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Figure 2. Using the app to record blood glucose and ketosis values. The logo and the second part
of the drop-down menu are reported in (A). An example of recording of the blood glucose value
(mg/dl) is reported in (B,C). An example of recording of the ketosis value (mmol/L) is reported
in (D,E).
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Figure 3. Using the app to record the anthropometric data and seizure values. The logo and the third
part of the drop-down menu are reported in (A). An example of recording of the anthropometric data
is reported in (B–E). An example of recording of the seizure values is reported in (F,G).
3.4. Different Channels of Communication through Which Caregivers Had Received Information
about the Ketogenic Diet
The results of the questionnaires, with the characterisations of the caregivers who
were involved in the survey and a detailed analysis of the informative booklets, were
presented in our previous study [21]. Here, we focus on a comparison between the group
that was given access only to the booklets (n = 18) and the group that also had access to
different web materials about the ketogenic diet (n = 22). All the caregivers were asked
about their overall satisfaction with the informative material that they received from the
medical centre following their child. Notably, the website was not fully available in 2016,
so no caregivers were asked to complete the sub-sections of the questionnaire regarding
the website. Interestingly, the caregivers with access to the web-based materials were
significantly more satisfied than those without any access (Booklets only vs. Booklets +
Web; 3.0, 2.0–3.0 vs. 4.0, 4.0–4.0; p ≤ 0.001; Figure 4A). Access to the information on the app
and the videos significantly increased caregivers’ positive attitudes towards the treatment,
in comparison to the attitude of caregivers with access only to the booklets (3.0, 2.0–3.0
vs. 4.0, 4.0–4.0; p ≤ 0.001; Figure 4B). The group with access to the web-based materials
also became more aware of the management of the diet, in comparison to those without
access to that kind of material (3.0, 2.0–4.0 vs. 4.0, 4.0–4.0; p ≤ 0.001; Figure 4C). Moreover,
caregivers with access to the app and the videos were significantly more motivated by
the informative materials to go on with the diet, in comparison to the other participants
in the survey (3.0, 2.0–3.3 vs. 4.0, 3.0–4.0; p = 0.002; Figure 4D). In comparison to the
control group, caregivers with access to web materials about the ketogenic diet significantly
thought that the information they received had helped them to explain the ketogenic diet
to their children (3.0, 2.0–3.0 vs. 4.0, 3.0–4.0; p = 0.001; Figure 4E) and other people involved
in the management of the diet (3.0, 2.0–4.0 vs. 4.0, 3.8–4.0; p = 0.001; Figure 4F). Finally,
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caregivers with access to the app were significantly more inclined to use the informative
materials to help another family choose the ketogenic diet than those without any access
(3.0, 2.0–4.0 vs. 4.0, 4.0–4.3; p = 0.004; Figure 4G).
Figure 4. Comparison between channels of communication through which caregivers received
information about the ketogenic diet. The group called “Booklets only” included caregivers with
access only to booklets/leaflets, whereas the group known as “Booklets + Web” consisted of caregivers
with access also to the KetApp and videos. Specifically, the two groups were compared in relation to
(A) the satisfaction about the level of information of the materials provided by the centres; (B) the
change in the attitude on the treatment after reading the informative materials; (C) the awareness of
the management of the ketogenic diet; (D) the motivation to go on with the ketogenic diet; (E,F) the
usefulness of the informative materials to explain the diet to children and other people involved in
the dietary management; (G) the usefulness of the informative materials in motivating other families
to choose the ketogenic diet (** p < 0.01, *** p < 0.001; Mann–Whitney test). The whiskers of the boxes
represent the minimum and maximum values. In addition to the values of median, the mean is also
represented by a +. KD, Ketogenic diet.
4. Discussion
This study aimed to assess the efficacy of giving caregivers access to e-health tech-
nologies for the management of epileptic children receiving a ketogenic diet in our Italian
centres. Specifically, the analysis was based on a questionnaire survey [21], which had
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at least the following advantages: (i) questionnaires were anonymous and caregivers felt
free to express their opinions; and (ii) questionnaires were more economic, faster, and
were considered more voluntary than interviews [3,24]. Our study demonstrated that the
use of a website about the ketogenic diet specially designed by health professionals, the
Italian app “KetApp”, and some videos of Keto recipes created by dieticians increased
the satisfaction of caregivers and their positive attitude towards the dietary treatment of
drug-resistant epilepsy. None of the caregivers stated that they strongly disagreed with the
positive contribution made by e-health technologies in promoting the continuation of the
ketogenic diet. Most caregivers would support the use of web-based materials, in addition
to booklets and leaflets, to introduce the treatment to children and other people involved
in the management of the diet. Eighty-two percent of the caregivers would recommend
the therapeutic treatment of drug-resistant epilepsy with the ketogenic diet after using
e-health technologies.
The application of a ketogenic diet is suitable for children and young infants in
paediatric intensive care units for neurological disorders. Indeed, it is mainly used in
cases of chronic refractoriness to antiepileptic drugs, but it is also a therapeutic option
for the acute stage of refractory/super-refractory status epilepticus [25]. The use of this
dietary treatment is challenging because of the critical status of the patients [25] and the
low variability, palatability, and tolerability of the diet itself [19]. Furthermore, a ketogenic
diet should be started as soon as possible, and an optimal management of the paediatric
patients receiving this dietary therapy is required from the beginning [26]. When conducted
properly, a ketogenic diet is tolerated [27] and it can induce an increased number of patients
achieving seizure freedom over time [14,28]. Then, a correct management of the ketogenic
diet is also important to avoid side effects [16,17,19], controversies [29], and, in some cases,
a phenomenon known as the rebound effect [30], which is characterised by a paradoxical
seizure worsening [31]. Thus, the initiation and maintenance of the dietary treatment
are the result of concomitant efforts of paediatric neurologists/epileptologists, dieticians,
families and other patients’ caregivers [32].
Nowadays, apps are innovative tools to manage and store patients’ records [16].
Through a smart device, it is possible to collect a huge amount of information quickly,
and to represent the data of interest using tables, graphs, or charts to promote easy inter-
pretation [2]. Recently, it was demonstrated that an automatic ketogenic diet planning
application could decrease the burden of hand computation, offer an extensive variety of
food choices, and help the users follow the therapeutic treatment recommended by the
dietician [33]. Then, the importance of e-health technologies was also clear at the begin-
ning of the COVID-19 pandemic, when a large variety of digital applications, processes,
and platforms were adopted to continue providing knowledge to patients and caregivers,
without affecting the social distancing efforts [8]. In Argentina, an interesting patient
satisfaction survey demonstrated for the first time that caregivers were pleased with the
management of the dietary treatment through WhatsApp, which could represent a simple
but comprehensive tool to manage the ketogenic diet in patients living far from the treating
centre or during difficult conditions, such as the ongoing crisis [3]. According to our survey,
we also demonstrated the importance of the mobile applications in the management of
the dietary treatment in our centres and its usefulness in maximising the success of the
ketogenic diet.
Moreover, specific videos and websites designed by health professionals could become
additional instruments for providing informative material about dietary management
strategies. Indeed, it was reported that most caregivers and patients preferred to gather
information about their diseases and treatment alternatives from different sources, such
as from their healthcare providers, other patients or families, and on the Internet [34].
However, the web presents a wide range of information, some of which is erroneous.
Misleading information could increase, in particular, the risks of improper self-diagnosis,
the use of damaging therapeutic attempts, and the delay of visits to health professionals.
Given the extensive use of the Internet and its remarkable impact, it was suggested that
Nutrients 2021, 13, 1240 11 of 13
health websites might be designed to provide accurate information, helping patients and
their families make better healthcare decisions [34]. In agreement with the literature, our
survey revealed that a website of this kind would be appreciated, in addition to paper-
based materials, because it could be continually updated with information on a wide range
of topics [21]. For this reason, we recently decided to go further with the improvement of
the website, “www.dietachetogenica.unimore.it” (accessed on 31 March 2021), to offer free
selective informative material about the ketogenic diet.
Overall, our survey demonstrated a high degree of satisfaction among the survey
participants with the management of the ketogenic diet by using web-based materials
among the survey participants. Nevertheless, the study has some obvious limitations,
mainly related to the time at which the study was conducted and then the current conditions
that could have affected the results. Another limitation, not least in importance, is that
82% of survey participants were treated in one centre. In future, it will be necessary to
increase the number of Italian centres included in the survey to make the results much
more representative of Italy. On the other hand, the study could represent a cue for dietary
management during the ongoing crisis, as well as after the coronavirus outbreak resolves.
5. Conclusions
Our survey showed that caregivers with free access to web-based materials were
markedly more satisfied than those with access only to paper-based materials. Their
management of the ketogenic diet appeared to be more successful when they had different
options. Thus, we confirm that different kinds of e-health applications should be used
simultaneously, as complementary resources, in the management of the ketogenic diet.
Finally, we suggest that our study could serve as a starting point for the management of
the ketogenic diet in Italy, during the ongoing COVID-19 pandemic and after it resolves.
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